Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 15:43 (1419 d 01:55 ago) – Posting: # 18981
Views: 11,104

Hi ElMaestro,

» This is purely hypothetical for me. As far as I recall, I have not ever faced such a situation where two test formulations targeting the same authority were heads-on compared in a pivotal trial. I have faced it numerous times in pilot trials, but here the choice of formulation rarely is based on the CI but just on the observed GMR.

Precisely. But then, isn't this whole discussion on alpha correction purely hypothetical too ?

Sorry if I'm spoiling a nice thread...

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,073 posts in 4,629 threads, 1,565 registered users;
online 18 (3 registered, 15 guests [including 10 identified bots]).
Forum time: Monday 17:39 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5